经皮左锁骨下动脉药盒系统置入法的临床应用  

Clinical application of percutaneous port-catheter system implantation via left subclavian artery

作　　者：冯晓波[1] 罗成刚[1] 李子林[1] 杨大勇[1] 万洁[1] 张勇[1] 

机构地区：[1]湖北省肿瘤医院放射科,武汉430079

出　　处：《放射学实践》2011年第7期759-761,共3页Radiologic Practice

摘　　要：目的:探讨经左锁骨下动脉导管药盒系统(PCS)置入术,在治疗腹部晚期恶性肿瘤中的操作方法及临床应用价值。方法:回顾分析52例腹部晚期恶性肿瘤患者行左锁骨下动脉药盒置入术的操作过程、技术要点及药盒系统的维护。结果:所有病例PCS置入术全部成功,仅有1例伤口渗血较多需重新止血包扎,1例留置管被刺破,拆开伤口皮肤,重新处理。结论:经皮穿刺左锁骨下动脉药盒置入术,具有操作方便、安全、并发症少,是动脉内化疗的一条安全可靠的途径。Objective： To investigate the clinical application and operation procedure of percutaneous port-catheter system Implantation via left subclavian artery（PCS） in the treatment of advanced malignant tumor of abdomen.Methods：52 patients with advanced malignant tumor within abdomen were treated with percutaneous port-catheter system implantation via left subclavian artery,the operation procedure,techniques and the management of PCS were retrospectively analyzed.Results：PCS were successfully implanted in all of these patients.Only one case had bleeding of wound and dressing for hemostasis was needed,another case had indwelling tube broken by puncture,and the suture of skin had to be removed and the wound repaired.Conclusion：Percutaneous port-catheter system implantation via left subclavian artery is a convenient,safe technique for intra-arterial chemotherapy with less complication.

关 键 词：放射学 介入性 肝肿瘤 胰腺肿瘤 治疗 

分 类 号：R735[医药卫生—肿瘤] R814.41[医药卫生—临床医学]